Originally employed in atomic physics, mass spectrometry is now an indispensable tool in modern science, and importantly ...

Just a year ago, the GenAI buzz in pharma felt like the start of a gold rush. Leaders greenlit pilots. Teams spun up proof-of ...

From the practical wisdom of emphasising exercise to improve survival in colon cancer to the association of glucagon-like ...

However, in both cases, NICE immediately published draft guidance that concluded the anti-amyloid drugs were too expensive to ...

Gilead is now waiting for regulatory decisions on the twice-yearly PrEP in Europe and other markets, including South Africa ...